ニューロペプチドY受容体タイプ2の世界市場（～2026年）

• 英文タイトル：Global Neuropeptide Y Receptor Type 2 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY08115 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はニューロペプチドY受容体タイプ2のグローバル市場について調査・分析したレポートです。種類別（XL-310、NN-9748、GT-002、その他）市場規模、用途別（肥満、てんかん、2型糖尿病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ニューロペプチドY受容体タイプ2の競争状況、市場シェア ・世界のニューロペプチドY受容体タイプ2市場：種類別市場規模 2015年-2020年（XL-310、NN-9748、GT-002、その他） ・世界のニューロペプチドY受容体タイプ2市場：種類別市場規模予測 2021年-2026年（XL-310、NN-9748、GT-002、その他） ・世界のニューロペプチドY受容体タイプ2市場：用途別市場規模 2015年-2020年（肥満、てんかん、2型糖尿病、その他） ・世界のニューロペプチドY受容体タイプ2市場：用途別市場規模予測 2021年-2026年（肥満、てんかん、2型糖尿病、その他） ・北米のニューロペプチドY受容体タイプ2市場分析：米国、カナダ ・ヨーロッパのニューロペプチドY受容体タイプ2市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのニューロペプチドY受容体タイプ2市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のニューロペプチドY受容体タイプ2市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのニューロペプチドY受容体タイプ2市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Gila Therapeutics Inc、Novo Nordisk A/S、XL-protein GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Neuropeptide Y Receptor Type 2 Market
The global Neuropeptide Y Receptor Type 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Neuropeptide Y Receptor Type 2 Scope and Market Size
Neuropeptide Y Receptor Type 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuropeptide Y Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Neuropeptide Y Receptor Type 2 market is segmented into
XL-310
NN-9748
GT-002
Others

Segment by Application, the Neuropeptide Y Receptor Type 2 market is segmented into
Obesity
Epilepsy
Type 2 Diabetes
Others

Regional and Country-level Analysis
The Neuropeptide Y Receptor Type 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Neuropeptide Y Receptor Type 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neuropeptide Y Receptor Type 2 Market Share Analysis
Neuropeptide Y Receptor Type 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuropeptide Y Receptor Type 2 business, the date to enter into the Neuropeptide Y Receptor Type 2 market, Neuropeptide Y Receptor Type 2 product introduction, recent developments, etc.

The major vendors covered:
Gila Therapeutics Inc
Novo Nordisk A/S
XL-protein GmbH
…

レポート目次

---

1 Study Coverage
1.1 Neuropeptide Y Receptor Type 2 Product Introduction
1.2 Market Segments
1.3 Key Neuropeptide Y Receptor Type 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neuropeptide Y Receptor Type 2 Market Size Growth Rate by Type
1.4.2 XL-310
1.4.3 NN-9748
1.4.4 GT-002
1.4.5 Others
1.5 Market by Application
1.5.1 Global Neuropeptide Y Receptor Type 2 Market Size Growth Rate by Application
1.5.2 Obesity
1.5.3 Epilepsy
1.5.4 Type 2 Diabetes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Neuropeptide Y Receptor Type 2 Market Size, Estimates and Forecasts
2.1.1 Global Neuropeptide Y Receptor Type 2 Revenue 2015-2026
2.1.2 Global Neuropeptide Y Receptor Type 2 Sales 2015-2026
2.2 Global Neuropeptide Y Receptor Type 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neuropeptide Y Receptor Type 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neuropeptide Y Receptor Type 2 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Neuropeptide Y Receptor Type 2 Competitor Landscape by Players
3.1 Neuropeptide Y Receptor Type 2 Sales by Manufacturers
3.1.1 Neuropeptide Y Receptor Type 2 Sales by Manufacturers (2015-2020)
3.1.2 Neuropeptide Y Receptor Type 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Neuropeptide Y Receptor Type 2 Revenue by Manufacturers
3.2.1 Neuropeptide Y Receptor Type 2 Revenue by Manufacturers (2015-2020)
3.2.2 Neuropeptide Y Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neuropeptide Y Receptor Type 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neuropeptide Y Receptor Type 2 Revenue in 2019
3.2.5 Global Neuropeptide Y Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neuropeptide Y Receptor Type 2 Price by Manufacturers
3.4 Neuropeptide Y Receptor Type 2 Manufacturing Base Distribution, Product Types
3.4.1 Neuropeptide Y Receptor Type 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuropeptide Y Receptor Type 2 Product Type
3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Type 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neuropeptide Y Receptor Type 2 Market Size by Type (2015-2020)
4.1.1 Global Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020)
4.1.2 Global Neuropeptide Y Receptor Type 2 Revenue by Type (2015-2020)
4.1.3 Neuropeptide Y Receptor Type 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neuropeptide Y Receptor Type 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Neuropeptide Y Receptor Type 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Neuropeptide Y Receptor Type 2 Revenue Forecast by Type (2021-2026)
4.2.3 Neuropeptide Y Receptor Type 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neuropeptide Y Receptor Type 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Neuropeptide Y Receptor Type 2 Market Size by Application (2015-2020)
5.1.1 Global Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020)
5.1.2 Global Neuropeptide Y Receptor Type 2 Revenue by Application (2015-2020)
5.1.3 Neuropeptide Y Receptor Type 2 Price by Application (2015-2020)
5.2 Neuropeptide Y Receptor Type 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Neuropeptide Y Receptor Type 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Neuropeptide Y Receptor Type 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuropeptide Y Receptor Type 2 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Neuropeptide Y Receptor Type 2 by Country
6.1.1 North America Neuropeptide Y Receptor Type 2 Sales by Country
6.1.2 North America Neuropeptide Y Receptor Type 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neuropeptide Y Receptor Type 2 Market Facts & Figures by Type
6.3 North America Neuropeptide Y Receptor Type 2 Market Facts & Figures by Application

7 Europe
7.1 Europe Neuropeptide Y Receptor Type 2 by Country
7.1.1 Europe Neuropeptide Y Receptor Type 2 Sales by Country
7.1.2 Europe Neuropeptide Y Receptor Type 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuropeptide Y Receptor Type 2 Market Facts & Figures by Type
7.3 Europe Neuropeptide Y Receptor Type 2 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Neuropeptide Y Receptor Type 2 by Region
8.1.1 Asia Pacific Neuropeptide Y Receptor Type 2 Sales by Region
8.1.2 Asia Pacific Neuropeptide Y Receptor Type 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neuropeptide Y Receptor Type 2 Market Facts & Figures by Type
8.3 Asia Pacific Neuropeptide Y Receptor Type 2 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Neuropeptide Y Receptor Type 2 by Country
9.1.1 Latin America Neuropeptide Y Receptor Type 2 Sales by Country
9.1.2 Latin America Neuropeptide Y Receptor Type 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neuropeptide Y Receptor Type 2 Market Facts & Figures by Type
9.3 Central & South America Neuropeptide Y Receptor Type 2 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Neuropeptide Y Receptor Type 2 by Country
10.1.1 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country
10.1.2 Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Facts & Figures by Type
10.3 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Facts & Figures by Application

11 Company Profiles
11.1 Gila Therapeutics Inc
11.1.1 Gila Therapeutics Inc Corporation Information
11.1.2 Gila Therapeutics Inc Description and Business Overview
11.1.3 Gila Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Products Offered
11.1.5 Gila Therapeutics Inc Related Developments
11.2 Novo Nordisk A/S
11.2.1 Novo Nordisk A/S Corporation Information
11.2.2 Novo Nordisk A/S Description and Business Overview
11.2.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Products Offered
11.2.5 Novo Nordisk A/S Related Developments
11.3 XL-protein GmbH
11.3.1 XL-protein GmbH Corporation Information
11.3.2 XL-protein GmbH Description and Business Overview
11.3.3 XL-protein GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 XL-protein GmbH Neuropeptide Y Receptor Type 2 Products Offered
11.3.5 XL-protein GmbH Related Developments
11.1 Gila Therapeutics Inc
11.1.1 Gila Therapeutics Inc Corporation Information
11.1.2 Gila Therapeutics Inc Description and Business Overview
11.1.3 Gila Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Products Offered
11.1.5 Gila Therapeutics Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neuropeptide Y Receptor Type 2 Market Estimates and Projections by Region
12.1.1 Global Neuropeptide Y Receptor Type 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Neuropeptide Y Receptor Type 2 Revenue Forecast by Regions 2021-2026
12.2 North America Neuropeptide Y Receptor Type 2 Market Size Forecast (2021-2026)
12.2.1 North America: Neuropeptide Y Receptor Type 2 Sales Forecast (2021-2026)
12.2.2 North America: Neuropeptide Y Receptor Type 2 Revenue Forecast (2021-2026)
12.2.3 North America: Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Neuropeptide Y Receptor Type 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Neuropeptide Y Receptor Type 2 Sales Forecast (2021-2026)
12.3.2 Europe: Neuropeptide Y Receptor Type 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neuropeptide Y Receptor Type 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neuropeptide Y Receptor Type 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neuropeptide Y Receptor Type 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neuropeptide Y Receptor Type 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Neuropeptide Y Receptor Type 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Neuropeptide Y Receptor Type 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Neuropeptide Y Receptor Type 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neuropeptide Y Receptor Type 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neuropeptide Y Receptor Type 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neuropeptide Y Receptor Type 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neuropeptide Y Receptor Type 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Neuropeptide Y Receptor Type 2 Market Segments
Table 2. Ranking of Global Top Neuropeptide Y Receptor Type 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neuropeptide Y Receptor Type 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of XL-310
Table 5. Major Manufacturers of NN-9748
Table 6. Major Manufacturers of GT-002
Table 7. Major Manufacturers of Others
Table 8. Global Neuropeptide Y Receptor Type 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Neuropeptide Y Receptor Type 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Neuropeptide Y Receptor Type 2 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 12. Global Neuropeptide Y Receptor Type 2 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Neuropeptide Y Receptor Type 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Neuropeptide Y Receptor Type 2 Sales Share by Manufacturers (2015-2020)
Table 15. Global Neuropeptide Y Receptor Type 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Neuropeptide Y Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropeptide Y Receptor Type 2 as of 2019)
Table 17. Neuropeptide Y Receptor Type 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Neuropeptide Y Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Neuropeptide Y Receptor Type 2 Price (2015-2020) (USD/Pcs)
Table 20. Neuropeptide Y Receptor Type 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Neuropeptide Y Receptor Type 2 Product Type
Table 22. Date of International Manufacturers Enter into Neuropeptide Y Receptor Type 2 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Neuropeptide Y Receptor Type 2 Sales Share by Type (2015-2020)
Table 26. Global Neuropeptide Y Receptor Type 2 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Neuropeptide Y Receptor Type 2 Revenue Share by Type (2015-2020)
Table 28. Neuropeptide Y Receptor Type 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Neuropeptide Y Receptor Type 2 Sales Share by Application (2015-2020)
Table 31. North America Neuropeptide Y Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 33. North America Neuropeptide Y Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Neuropeptide Y Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 35. North America Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 37. North America Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 39. Europe Neuropeptide Y Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 41. Europe Neuropeptide Y Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Neuropeptide Y Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 43. Europe Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 45. Europe Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Neuropeptide Y Receptor Type 2 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Neuropeptide Y Receptor Type 2 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Neuropeptide Y Receptor Type 2 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 55. Latin America Neuropeptide Y Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Neuropeptide Y Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Neuropeptide Y Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 61. Latin America Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 71. Gila Therapeutics Inc Corporation Information
Table 72. Gila Therapeutics Inc Description and Major Businesses
Table 73. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Gila Therapeutics Inc Product
Table 75. Gila Therapeutics Inc Recent Development
Table 76. Novo Nordisk A/S Corporation Information
Table 77. Novo Nordisk A/S Description and Major Businesses
Table 78. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Novo Nordisk A/S Product
Table 80. Novo Nordisk A/S Recent Development
Table 81. XL-protein GmbH Corporation Information
Table 82. XL-protein GmbH Description and Major Businesses
Table 83. XL-protein GmbH Neuropeptide Y Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. XL-protein GmbH Product
Table 85. XL-protein GmbH Recent Development
Table 86. Global Neuropeptide Y Receptor Type 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 87. Global Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Regions (2021-2026)
Table 88. Global Neuropeptide Y Receptor Type 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 89. Global Neuropeptide Y Receptor Type 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 90. North America: Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 91. North America: Neuropeptide Y Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Europe: Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 93. Europe: Neuropeptide Y Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Asia Pacific: Neuropeptide Y Receptor Type 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 95. Asia Pacific: Neuropeptide Y Receptor Type 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 96. Latin America: Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. Latin America: Neuropeptide Y Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Middle East and Africa: Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Middle East and Africa: Neuropeptide Y Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 101. Key Challenges
Table 102. Market Risks
Table 103. Main Points Interviewed from Key Neuropeptide Y Receptor Type 2 Players
Table 104. Neuropeptide Y Receptor Type 2 Customers List
Table 105. Neuropeptide Y Receptor Type 2 Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuropeptide Y Receptor Type 2 Product Picture
Figure 2. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Type in 2020 & 2026
Figure 3. XL-310 Product Picture
Figure 4. NN-9748 Product Picture
Figure 5. GT-002 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Application in 2020 & 2026
Figure 8. Obesity
Figure 9. Epilepsy
Figure 10. Type 2 Diabetes
Figure 11. Others
Figure 12. Neuropeptide Y Receptor Type 2 Report Years Considered
Figure 13. Global Neuropeptide Y Receptor Type 2 Market Size 2015-2026 (US$ Million)
Figure 14. Global Neuropeptide Y Receptor Type 2 Sales 2015-2026 (K Pcs)
Figure 15. Global Neuropeptide Y Receptor Type 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Region (2015-2020)
Figure 17. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Region in 2019
Figure 18. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Region (2015-2020)
Figure 19. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Region in 2019
Figure 20. Global Neuropeptide Y Receptor Type 2 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Neuropeptide Y Receptor Type 2 Revenue in 2019
Figure 22. Neuropeptide Y Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Type (2015-2020)
Figure 24. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Type in 2019
Figure 25. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Type (2015-2020)
Figure 26. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Type in 2019
Figure 27. Global Neuropeptide Y Receptor Type 2 Market Share by Price Range (2015-2020)
Figure 28. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
Figure 29. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Application in 2019
Figure 30. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Application (2015-2020)
Figure 31. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Application in 2019
Figure 32. North America Neuropeptide Y Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Neuropeptide Y Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Country in 2019
Figure 35. North America Neuropeptide Y Receptor Type 2 Revenue Market Share by Country in 2019
Figure 36. U.S. Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Neuropeptide Y Receptor Type 2 Market Share by Type in 2019
Figure 41. North America Neuropeptide Y Receptor Type 2 Market Share by Application in 2019
Figure 42. Europe Neuropeptide Y Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Neuropeptide Y Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Country in 2019
Figure 45. Europe Neuropeptide Y Receptor Type 2 Revenue Market Share by Country in 2019
Figure 46. Germany Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Neuropeptide Y Receptor Type 2 Market Share by Type in 2019
Figure 57. Europe Neuropeptide Y Receptor Type 2 Market Share by Application in 2019
Figure 58. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Neuropeptide Y Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Neuropeptide Y Receptor Type 2 Revenue Market Share by Region in 2019
Figure 62. China Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Neuropeptide Y Receptor Type 2 Market Share by Type in 2019
Figure 85. Asia Pacific Neuropeptide Y Receptor Type 2 Market Share by Application in 2019
Figure 86. Latin America Neuropeptide Y Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Neuropeptide Y Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share by Country in 2019
Figure 89. Latin America Neuropeptide Y Receptor Type 2 Revenue Market Share by Country in 2019
Figure 90. Mexico Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Neuropeptide Y Receptor Type 2 Market Share by Type in 2019
Figure 97. Latin America Neuropeptide Y Receptor Type 2 Market Share by Application in 2019
Figure 98. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Market Share by Country in 2019
Figure 102. Turkey Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Neuropeptide Y Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Neuropeptide Y Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Share by Type in 2019
Figure 109. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Share by Application in 2019
Figure 110. North America Neuropeptide Y Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Neuropeptide Y Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Neuropeptide Y Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Neuropeptide Y Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Neuropeptide Y Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Neuropeptide Y Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Neuropeptide Y Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Neuropeptide Y Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---